Drug effects on regional cerebral blood flow in focal cerebrovascular disease.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D001549:Benzamides / Q000494:pharmacology; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000503:physiopathology*; D003911:Dextrans / Q000494:pharmacology; D006400:Hematocrit; D006801:Humans; D010208:Papaverine / Q000494:pharmacology; D013012:Sorbitol / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D001549:Benzamides; D003911:Dextrans; D014665:Vasodilator Agents; D013012:Sorbitol; D013806:Theophylline; D010208:Papaverine